Delta 9 Cannabis (TSE:DN) has released an update.
Delta 9 Cannabis Inc. has initiated a sales and investment solicitation process for its subsidiary Delta 9 Bio-Tech, seeking potential deals for a sale or investment in the company’s assets, which includes a Health Canada approved cannabis production facility. The company highlights the subsidiary’s competitive cost structure for cannabis production and potential for expansion with modest capital investment. Interested parties are invited to submit formal offers by October 28, 2024.
For further insights into TSE:DN stock, check out TipRanks’ Stock Analysis page.
